Quantum Biopharma QNTM
NASDAQ QNTM
$3.44 +0.02 (+0.58%)
At close: Oct 2, 2026 · 4:00 PM EDT

Quantum Biopharma (QNTM) Other Accumulated Expenses (2018 - 2020)

Updated

Quantum Biopharma (QNTM) reported Other Accumulated Expenses of $3.02 million for Q2 2020.

Analysis

Quantum Biopharma (QNTM) Other Accumulated Expenses (2018 - 2020) Analysis & Trends

At the end of FY2019, Quantum Biopharma posted Other Accumulated Expenses of $3.37 million.

  • By year, Other Accumulated Expenses came in at -$431,941 in FY2018.
  • The Q2 2020 figure ranks as the lowest quarterly Other Accumulated Expenses since Q4 2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Quantum Biopharma 13.37 Mn 1.18 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2020 3.02 Mn
Dec 31, 2019 3.38 Mn
Dec 31, 2018 1.32 Mn
API Access

Quantum Biopharma Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=QNTM&period=max&api_key=YOUR_API_KEY